• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec19
Central Economic Work Conference Emphasizes Innovation Leadership in Pharmaceutical Industry
06:22
Dec5
Jinfang Medicine Launches Phase III Trial for GFH375
00:18
Oct21
Jinfang Pharmaceutical-B Completes First Patient Enrollment in GFH375 Combination Therapy Study
23:36
Gendeutecnology-B Exercises Over-allotment Option to Issue 13.386 Million H-Share
08:36
Oct20
JinFang Pharmaceutical Announces Promising Data for GFH375 in KRAS G12D Mutant Pancreatic Cancer
00:56
Oct16
Jinfang Pharmaceutical-B Exercises Over-allotment Option Fully
12:08

Schedules & Filings

Schedules
Filings
Sep30
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 48.57 M, Net Income -382.32 M, EPS -14.7844

Sep19
IPO(CST)

Listing Price HKD 20.39

Sep10
Earning Release(CST)

FY2024 Annual Earning Release (HKD) Revenue 113.34 M, Net Income -733.53 M, EPS -28.366

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
06038
0.425
+32.81%
+0.105
02315
35.380
+23.28%
+6.680
02330
0.232
+20.83%
+0.040
02231
0.099
+19.28%
+0.016
01875
2.500
+19.05%
+0.400
00209
0.173
+16.89%
+0.025
08082
0.043
+16.22%
+0.006
08076
0.043
+16.22%
+0.006
02028
0.080
+15.94%
+0.011
01722
0.086
+14.67%
+0.011
View More